Apple and OpenEvidence have launched a study centered around an experimental AI-powered health chat application, hinting at potential new directions for both companies. The study aims to understand how consumers interact with and trust conversational health AI chatbots.
TL;DR
- Apple and OpenEvidence have collaborated on a study to evaluate an AI health chatbot, focusing on user trust and comprehension.
- The study was announced at the HLTH conference in Las Vegas, with both companies highlighting their respective strengths in consumer and clinical trust.
- This partnership could signal new directions for both Apple and OpenEvidence in the health tech sector.
What happened
At the HLTH conference in Las Vegas, Apple and OpenEvidence unveiled a study based on an experimental AI-powered health chat application. The study aims to better understand how consumers interact with and trust conversational health AI chatbots.
Sumbul Desai, Apple's vice president of health and fitness, emphasized the company's commitment to scientific rigor in the study. She noted that the study will explore what builds user trust, how people comprehend responses, and the quality of responses.
Daniel Nadler, CEO of OpenEvidence, highlighted the complementary strengths of both companies. He stated that OpenEvidence is the most trusted brand among doctors, while Apple is the most trusted brand among consumers, especially health consumers.
Why it matters
This collaboration could pave the way for new health tech products from both Apple and OpenEvidence, leveraging their respective strengths in consumer and clinical trust.
For developers and startups, this study could provide valuable insights into the future of AI-powered health chatbots and how they can be integrated into consumer health products.
Investors may see this partnership as a strategic move that could enhance both companies' positions in the rapidly growing health tech market.
Key facts
- The study was launched at the HLTH conference in Las Vegas.
- Sumbul Desai, Apple's vice president of health and fitness, announced the study on stage.
- Daniel Nadler, CEO of OpenEvidence, highlighted the complementary strengths of both companies.
- The study aims to understand user trust, comprehension, and the quality of responses in AI health chatbots.
- OpenEvidence is described as the most trusted brand among doctors.
- Apple is described as the most trusted brand among consumers, especially health consumers.
Context
This partnership comes at a time when AI-powered health applications are gaining traction. Both Apple and OpenEvidence are well-positioned to lead in this space, with Apple's strong consumer brand and OpenEvidence's clinical expertise.
The study could set a new standard for how AI health chatbots are developed and integrated into consumer health products, potentially influencing the broader AI health tech industry.
